ClinicalTrials.Veeva

Menu

Efficacy Of A PVP-I Fluoride Varnish

A

Advantage Dental Services

Status and phase

Completed
Phase 2

Conditions

Dental Caries

Treatments

Drug: Standard varnish
Drug: Test varnish

Study type

Interventional

Funder types

Industry

Identifiers

NCT03082196
2016-12-02

Details and patient eligibility

About

The purpose of the study is to determine the efficacy of Advantage Anti-Caries Varnish. Single-center, double-blind, controlled Phase 2 study with parallel groups of children. Subjects will be stratified by early childhood education center and then randomized to receive either test varnish or control varnish topically to the teeth. Treatment will be administered quarterly for up to 24 months. The primary outcome is surface-level primary molar caries increment (d2-4mfs) at 24- months post baseline.

Full description

Objectives:

Primary

  • To determine if Advantage Anti-Caries Varnish (test varnish) is superior to a control varnish containing only fluoride in the prevention of new caries lesions.

Secondary

  • To establish that the response of child participants to the test varnish was not inferior to the control varnish

Enrollment

284 patients

Sex

All

Ages

60 to 84 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. The subject's parent or legal guardian must provide signed and dated informed consent (parent permission form).
  2. The subject's parent or legal guardian of the subject must be willing and able to comply with study requirements.
  3. The subject is aged 60-84 months at the time of enrollment.
  4. The subject must be in good general health as evidenced by parent report.

Exclusion criteria

  1. Known allergy to iodine
  2. Known allergy to seafood
  3. Known hypersensitivity to fluoride varnish
  4. Diagnosis of thyroid disease
  5. Chronic, prophylactic use of antibiotics
  6. Treatment with another investigational drug or other intervention within 30 days preceding the Baseline Visit.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

284 participants in 2 patient groups

Test varnish
Experimental group
Description:
Advantage Anti-Caries Varnish. The active ingredients are Povidone Iodine and Sodium Fluoride .
Treatment:
Drug: Test varnish
Standard varnish
Active Comparator group
Description:
The active control varnish will be the same fluoride varnish without iodine with an appropriate FDA approved food dye added to match the color of the test agent. There will be no difference in the treatment and control varnishes except for the povidone iodine.
Treatment:
Drug: Standard varnish

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems